DNS - Piperacilin / tazobaktam
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1824/2021/ÚVN + 12-173/2021-1470 + S-001674/21 | 16. 12. 2021 | Fresenius Kabi s.r.o. | 4 272 576,00 | 3 884 160,00 | 4 272 576,00 | 3 884 160,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| KS VNB info z RS.pdf | Smlouva | 18. 01. 2022 10:59 | Dokument není zavirovaný | ||
| KS VNB Piperacilin-tazo anonymized.pdf | Smlouva | 18. 01. 2022 10:59 | Dokument není zavirovaný | ||
| KS VNOL info z RS.pdf | Smlouva | 18. 01. 2022 10:59 | Dokument není zavirovaný | ||
| KS VNOL Piperacilin-tazo anonymized.pdf | Smlouva | 18. 01. 2022 10:59 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| PHARMOS, a.s. | Ostrava | |||||
| Fresenius Kabi s.r.o. | Praha 4 | |||||
| ViaPharma s.r.o. | Praha | |||||
| CZ Pharma s.r.o. | Kostelec nad Černými lesy | |||||
| PHOENIX lékárenský velkoobchod, s.r.o. | Praha |
Price Actually Paid in Each Year of Performance
| 1824/2021/ÚVN + 12-173/2021-1470 + S-001674/21 | 2023 | 610 368,00 | 554 879,92 |
| 1824/2021/ÚVN + 12-173/2021-1470 + S-001674/21 | 2022 | 1 400 902,50 | 1 273 547,73 |
| 1824/2021/ÚVN + 12-173/2021-1470 + S-001674/21 | 2021 | 63 580,00 | 57 802,73 |